IntelliGenes, a new software at Rutgers Health, uses artificial intelligence and machine learning to measure the significance of genomic biomarkers, potentially predicting diseases. The software, which merges traditional statistical methods with state-of-the-art algorithms, is intuitive enough for non-experts to use. In a study, IntelliGenes was used to discover novel biomarkers and accurately predict cardiovascular disease.
Group-IB’s Threat Intelligence and Defence Centre Equip Undergraduates with Sophisticated Cybersecurity Technologies to Boost Threat Analysis and Enhance Cyber Resilience for Campus Start-ups
Hey there from the heart of the San Francisco Bay Area! It’s an absolute pleasure to have you back again for our chat on some
